Archive

Filter

Shares of Argos Therapeutics (NSDQ: ARGS), a development stage biotech company for personalized cancer treatments, fell sharply Feb. 22 after the company announced it would halt its phase 3 trial of its Rocapuldencel-T drug in combination with Sunitinib for treating metastatic renal cell carcinoma (kidney cancer) in children. Unfortunately, the… Read More

I am recommending the purchase of United Healthcare June 16, 2017 165 Call (UNH_170616100C16500) up to $5.  United is the largest health insurer in the U.S. The stock has fallen in sympathy with Molina Healthcare (NYSE: MOH) as the latter missed its Q$ earnings and announced that it is likely… Read More